Product Information

AMLODIPINE-OLMESARTAN 10-20 MG is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.2626 per EA under NDC 33342019210. Its NADAC has been published 488 times since Feb 22, 2017.

AMLODIPINE-OLMESARTAN 10-20 MG

AMLODIPINE and OLMESARTAN medoxomil
$0.2626per EA

Strength

10; 20 mg/1; mg/1

NDC

33342019210

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA206884

On Market Since

10/27/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has been published 488 times since Feb 22, 2017, and over the history we have for it it has declined 72.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2626 per EA
All-time high$0.9788 (Oct 11, 2017)
All-time low$0.2626 (Jun 17, 2026)
52-week high$0.3713
52-week low$0.2626
Median price$0.4533
Average price$0.5401
Largest weekly change+68.6% (Nov 22, 2023)
Weeks tracked488
Tracking sinceFeb 22, 2017

Price History

1W

0.0%

1M

-11.1%

3M

-13.7%

6M

-18.2%

1Y

-27.7%

3Y

-22.0%

5Y

-42.3%

All

-72.9%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE-OLMESARTAN 10-20 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 10-20 MG, manufactured by Macleods Pharmaceuticals Limited, is $0.2626 per EA (NDC 33342019210), effective Jun 24, 2026.

How has the price of AMLODIPINE-OLMESARTAN 10-20 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has declined 72.9%. It has been tracked across 488 weekly CMS publications since Feb 22, 2017.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 10-20 MG?

Since Feb 22, 2017, the NADAC for AMLODIPINE-OLMESARTAN 10-20 MG has ranged from a low of $0.2626 (Jun 17, 2026) to a high of $0.9788 (Oct 11, 2017), with a median of $0.4533 per EA.

Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 10-20 MG?

1 NADAC-published product shares the same active ingredient, strength, and dosage form as AMLODIPINE-OLMESARTAN 10-20 MG, but none are currently priced below it.

Who manufactures AMLODIPINE-OLMESARTAN 10-20 MG?

AMLODIPINE-OLMESARTAN 10-20 MG (NDC 33342019210) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.